OpenBilldrug price receipt

NADAC week of 2026-10-14

GAVILYTE-N SOLUTION

FDA nonproprietary name: polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate

For 1 mL

Pharmacies pay

<$0.01 filed

1 × $0.00461 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

<$0.01 filed

1 × $0.00397 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.86× estimated

Medicare paid 14% less than pharmacies pay.

Part D averages every strength and form sold under “Gavilyte-N” / “Sodium Chloride/NaHCO3/KCl/PEG” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.00 estimated

$0.00 + $0.00 (15%) + $5.00 fee per fill = $5.00

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GAVILYTE-N SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate, under the trade name “GAVILYTE-N”.

FDA gives its dosage form as powder, for solution and its route as oral.

The labeler, the company named on the label, is Lupin Pharmaceuticals,Inc.

FDA lists it under 2 Established Pharmacologic Classes: Osmotic Laxative and Potassium Salt.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 43386-0050-19.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay <$0.01 for 1 mL (1 × $0.00461 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Compared with its class

Its NADAC price is $0.00461 per ML filed.

Of the 38 other products in FDA’s Osmotic Laxative class priced per ML, 34 have a higher middle NADAC price and 3 a lower one; 1 has the same. The one in the middle is ANTACID ANTI-GAS MAX STR LIQ, at $0.01206 per ML filed (eff. 2026-09-23).

Of the 10 other products in FDA’s Potassium Salt class priced per ML, 7 have a higher middle NADAC price and 2 a lower one; 1 has the same. The one in the middle is PEG-3350 AND ELECTROLYTES SOLN, at $0.00465 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid <$0.01 for 1 mL, at an average of $0.00397 per ML in 2024 (2024-01-01 to 2024-12-31) for “Gavilyte-N” and “Sodium Chloride/NaHCO3/KCl/PEG”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 16,333 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for GAVILYTE-N SOLUTION labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Gavilyte-N / Sodium Chloride/NaHCO3/KCl/PEG: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 1 mL?
The FDA package description of NDC 43386-0050-19 (“438.4 g in 1 BOTTLE (43386-050-19)”) does not give one amount in mL, NADAC’s unit for this product. So the card starts at 1 ML; change it to match your prescription.